4//SEC Filing
Ziebell Mark R 4
Accession 0001683168-24-002942
CIK 0000704562other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 8:21 PM ET
Size
5.8 KB
Accession
0001683168-24-002942
Insider Transaction Report
Form 4
Ziebell Mark R
VP and General Counsel
Transactions
- Sale
Common Stock, $0.001 par value
2024-04-30$7.40/sh−1,643$12,157→ 64,834 total
Footnotes (2)
- [F1]Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSUs") which vested on April 9, 2024. This sale does not represent a discretionary trade by the reporting person. For further information regarding the RSUs vested on April 9, 2024, refer to footnotes 2, 3 and 4 of the reporting person's Form 4 filed with the SEC on April 11, 2024.
- [F2]Represents a weighted average sales price per share. These shares were sold at prices ranging from $7.33 to $7.40. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Avid Bioservices, Inc.
CIK 0000704562
Entity typeother
Related Parties
1- filerCIK 0001552642
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 8:21 PM ET
- Size
- 5.8 KB